Lymphoma B-cell
📧 Sign up to get email alerts when something new happens for Lymphoma B-cell.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-06EMA Authorised: Zynlonta (loncastuximab tesirine) — Swedish Orphan Biovitrum AB
EMA authorised Zynlonta (loncastuximab tesirine) for certain B-cell lymphomas with a conditional approval.